771581-03-4Relevant articles and documents
METHOD OF TREATMENT
-
, (2014/09/29)
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
-
Page/Page column 286-287, (2012/09/21)
The present invention relates to substituted 6,5 -fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.